Riverbridge Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Healthcare Services Group
HCSG
|
+$42.9M |
| 2 |
Verisk Analytics
VRSK
|
+$38.6M |
| 3 |
Dorman Products
DORM
|
+$22.8M |
| 4 |
Five Below
FIVE
|
+$19.5M |
| 5 |
Medtronic
MDT
|
+$10.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KMR
KINDER MORGAN MANAGEMENT LLC
KMR
|
+$25.4M |
| 2 |
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
|
+$10.7M |
| 3 |
FedEx
FDX
|
+$2.73M |
| 4 |
Baxter International
BAX
|
+$1.63M |
| 5 |
PepsiCo
PEP
|
+$889K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.13% |
| 2 | Industrials | 19.35% |
| 3 | Healthcare | 16.17% |
| 4 | Consumer Discretionary | 11.34% |
| 5 | Consumer Staples | 6.12% |
Similar funds
Riverbridge Partners's Q2 2014 Portfolio in Review
As of Q2 2014, Riverbridge Partners held 134 positions worth $5.74B, up 3.8% from $5.53B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Riverbridge Partners deployed $296M of net new capital in Q2 2014, opening 6 new positions and adding to 90 existing holdings. Its largest new stake was Verisk Analytics: 645,429 shares worth $38.7M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was KINDER MORGAN MANAGEMENT LLC, an estimated $25.4M trimmed.
- Riverbridge Partners's largest Q2 2014 buy was Verisk Analytics: 645,429 shares worth $38.7M.
- Riverbridge Partners added most to Healthcare Services Group in Q2 2014, an estimated $42.9M increase.
- Riverbridge Partners's biggest Q2 2014 reduction was KINDER MORGAN MANAGEMENT LLC, cutting an estimated $25.4M.
- Riverbridge Partners fully exited Baxter International in Q2 2014, selling an estimated $1.63M.
- Riverbridge Partners's ten largest holdings make up 29% of its $5.74B portfolio in Q2 2014.
- Riverbridge Partners opened 6 new positions and closed 5 in Q2 2014.
- Riverbridge Partners's portfolio value rose 3.8% quarter-over-quarter to $5.74B.
Based on Riverbridge Partners's 13F filing for Q2 2014, filed 31 Jul 2014.